Skip to main content

Sanofi's Acquisition of Genzyme - The CVR

Book Publication Date: Aug 2021
Description: Excerpts relating to the structure of Sanofi-Aventis' 2011 acquisition of Genzyme, a publicly held Massachusetts corporation, in a combination exchange offer followed by a second-step merger
Type: Contract Clauses
PLI Item #: 41252
Practice Area: Corporate law, Deal structuring, Mergers and acquisitions, Securities and other financial products, Tax, Tender offers

Keywords: "CVR"; "contingent valuation right"; "Sanofi's Acquisition of Genzyme"; "Genzyme common stock"; agreement governing Exchange Offer; issuance of CVRs; "transferability of CVRs"; reporting obligations; amendment of CVR agreement without the consent of CVR holders; parent purchase and cancellation right upon CVR failure event

Thank you for exploring PLI PLUS.
The content on this page is only available to subscribers.

To learn more about PLI PLUS subscriptions
please click on the link below or contact us at